TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
21,351
|
22,339
|
25,130 |
| Financial expenses |
25
|
48
|
16 |
| Earnings before taxes |
-1,031
|
159
|
4,102 |
| EBITDA |
-728
|
595
|
4,441 |
| Total assets |
26,101
|
24,974
|
22,656 |
| Current assets |
14,740
|
13,409
|
11,287 |
| Current liabilities |
6,666
|
4,303
|
3,274 |
| Equity capital |
16,279
|
16,215
|
16,112 |
| - share capital |
200
|
200
|
200 |
| Employees (average) |
12
|
14
|
14 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.4%
|
64.9%
|
71.1% |
| Turnover per employee |
1,779
|
1,596
|
1,795 |
| Profit as a percentage of turnover |
-4.8%
|
0.7%
|
16.3% |
| Return on assets (ROA) |
-3.9%
|
0.8%
|
18.2% |
| Current ratio |
221.1%
|
311.6%
|
344.7% |
| Return on equity (ROE) |
-6.3%
|
1.0%
|
25.5% |
| Change turnover |
-988
|
-2,791
|
3,140 |
| Change turnover % |
-4%
|
-11%
|
14% |
| Chg. No. of employees |
-2
|
0
|
0 |
| Chg. No. of employees % |
-14%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.